SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

14 Nov 2023 Evaluate
A minor change in the total revenue was seen in the September 2023 quarter. The total revenue for the quarter stood at Rs. 791.72 millions against Rs. 772.22 millions during year ago period.The Company's Net profit for the September 2023 quarter have declined marginally to Rs. 83.78  millions as against Rs. 119.18 millions reported during the corresponding quarter ended.Operating profit for the quarter ended September 2023 decreased to 143.91 millions as compared to 165.11 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 791.72 772.22 2.53 1570.11 1489.19 5.43 2903.24 2494.05 16.41
Other Income 10.93 22.08 -50.50 27.24 38.33 -28.93 66.72 26.30 153.69
PBIDT 143.91 165.11 -12.84 312.33 322.08 -3.03 624.85 530.25 17.84
Interest 16.49 11.98 37.65 29.22 16.72 74.76 42.87 11.55 271.17
PBDT 127.42 153.13 -16.79 283.11 305.36 -7.29 581.98 518.70 12.20
Depreciation 19.81 20.68 -4.21 39.24 28.70 36.72 66.21 29.05 127.92
PBT 107.61 132.45 -18.75 243.87 276.66 -11.85 515.77 489.65 5.33
TAX 23.83 13.27 79.58 58.73 48.61 20.82 100.18 109.37 -8.40
Deferred Tax 8.49 -12.53 -167.76 12.06 -8.92 -235.20 -2.06 10.53 -119.56
PAT 83.78 119.18 -29.70 185.14 228.05 -18.82 415.59 380.28 9.29
Equity 307.43 307.43 0.00 307.43 307.43 0.00 307.43 307.43 0.00
PBIDTM(%) 18.18 21.38 -14.99 19.89 21.63 -8.03 21.52 21.26 1.23

Sigachi Industries Share Price

22.52 -0.83 (-3.55%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×